WeSearch
Only 3% of US sickle cell patients receive red blood cell exchange for disease, researchers find

Only 3% of US sickle cell patients receive red blood cell exchange for disease, researchers find

https://www.theguardian.com/profile/tobi-thomas· ·4 min read · 0 reactions · 0 comments · 9 views
More from The Guardian — World world Compare coverage Trending Talk Blindspots Daily Sources Live wire
TL;DR · WeSearch summary

Researchers work at the National Heart, Lung, and Blood Institute on 8 February 2024 in Bethesda, Maryland. Photograph: Brendan Smialowski/AFP/Getty ImagesView image in fullscreenResearchers work at the National Heart, Lung, and Blood Institute on 8 February 2024 in Bethesda, Maryland. “There’s a gap between the number of providers who understand how to treat sickle cell disease.”Ivy noted the financial impact of the disease as a significant barrier, disclosing that roughly 80% of sickle cell patients are on Medicaid and face socioeconomic vulnerabilities.

Key facts
About this source

The Guardian — World publishes from United Kingdom and files mainly under world. We currently carry 4,129 of its stories.

Original article
The Guardian — World · https://www.theguardian.com/profile/tobi-thomas
Read full at The Guardian — World →

Story provenance

Source · retrieval · rights · ranking — open for full record
inspect →

Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.

Record

Original publisherThe Guardian — World
Canonical URLhttps://www.theguardian.com/society/2026/sep/27/sickle-cell-patients-red-blood-cell-exchange
Publication timeSun, 27 Sep 2026 12:00:04 GMT
Retrieval time2026-09-27T12:15:41.160Z
Last seen2026-09-27T12:15:41.160Z
Headline sourcePublisher (no WeSearch rewrite)
Excerpt sourcepublisher body
Excerpt methodFirst ~120 words (~800 chars) of extracted publisher body, fair-use limited.
SummaryWeSearch · cerebras-chat (WeSearch summarizer)
Summary source textcontentText
Citation coverageSummary is a WeSearch-generated derivative; primary citation is the original publisher URL.
ClusterZnM5aJwOR3Hf · 1 stories
Cluster logicGrouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison.
Ranking reasonStory pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking.
Publisher visitYes — open original
Substitutes article?No — link-out required for full text

Rights status (four layers)

Publisher-declared
No publisher-confirmed rights record for this source yet.
Machine-readable
No source-specific machine-readable restriction detected beyond the public feed.
WeSearch interpretation
WeSearch declared handling (basis: Derived from the published RSS/Atom feed). This is WeSearch policy, not a legal grant on the publisher's behalf.
Unknown
Retrieval and training permissions are not asserted unless the publisher confirms them.

WeSearch handling by dimension

Indexing May the item be indexed (stored, ranked, made findable)? Allowed
Snippet May a short excerpt of the publisher's text be shown? Allowed
AI summary May WeSearch generate its own short summary of the article? Limited
Retrieval / RAG May the content be exposed for third-party retrieval-augmented generation? Not asserted
Model training May the content be used to train AI models? Not asserted
Commercial reuse May the content be reused commercially? Not permitted

Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.

Opening excerpt (first ~120 words) tap to expand

Researchers work at the National Heart, Lung, and Blood Institute on 8 February 2024 in Bethesda, Maryland. Photograph: Brendan Smialowski/AFP/Getty ImagesView image in fullscreenResearchers work at the National Heart, Lung, and Blood Institute on 8 February 2024 in Bethesda, Maryland. Photograph: Brendan Smialowski/AFP/Getty ImagesSickle cell diseaseOnly 3% of US sickle cell patients receive red blood cell exchange for disease, researchers findVarious factors block sufferers of disease from receiving treatment that is effective and has widespread availabilityTobi Thomas Health and inequalities correspondent Sun 27 Sep 2026 08.00 EDTSharePrefer the Guardian on GoogleSickle cell patients are missing out on an effective treatment despite widespread US hospital access to the technology, new…

Excerpt limited to ~120 words for fair-use compliance. The full article is at The Guardian — World.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments